drugset / Trial / NCT01124279

Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult Subjects

NCT01124279 ↗

Phase 1 Completed 43 enrolled Amgen
RandomizedCrossoverOpen-labelBasic science

Summary

To determine the bioavailability and the effect of food on the pharmacokinetics under fasted and fed conditions

Timeline

Start
2010-05
Primary completion
2010-08
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject VIDUPIPRANT Small molecule — —

Indications

No indication recorded.